- Newly identified fusion genes in lung and colorectal cancer may guide treatment with 'targeted' drugs
Novel gene abnormalities discovered in a subpopulation of lung and colorectal tumors could potentially identify patients with Read More... - Dana-Farber study finds new subtype of ovarian cancer may be vulnerable to anti-angiogenic drugs
Scientists at Dana-Farber Cancer Institute have identified a subtype of ovarian cancer able to build its own blood vessels, s Read More... - Mayo Clinic study finds powerful myeloma treatment regimen shows promise for AL amyloidosis
Two studies published in Blood, the Journal of the American Society of Hematology (ASH), demonstrate preliminary success of a Read More... - Sanford-Burhham scientists develop new model of childhood brain cancer
Sanford-Burnham scientists have now developed a new mouse model for studying medulloblastoma. The animal model mimics the dea Read More... - Stanford scientists identify a treatment regimen that enhances the effectiveness of a breast cancer treatment
Breast cancers expressing the protein HER2 have a particularly poor prognosis. Treatment with trastuzumab (Herceptin) benefit Read More...
- Semuloparin Helps Prevent Thromboembolic Events in Patients Receiving Chemotherapy
Semuloparin, an ultra-low molecular weight heparin reduces the probability that a cancer patient undergoing chemotherapy has Read More... - The Hateful Patient
All those who walk through your doorway become your responsibility, at least until you either cure them, satisfy them, or in Read More... - Omega-3 Consumption Linked to Lower Incidence of Colon Polyps in Women
Researchers at Vanderbilt University Medical Center have found that eating omega-3 fatty acids regularly can result in preve Read More... - Novel Drug, MDV3100, Will Likely Have a Major Role in Prostate Cancer Treatment
The new drug, MDV3100, extended overall survival by 4.8 months and reduced the risk for death by 37% as compared to placebo i Read More... - Mother-To-Be and Cancer Patient—New Treatment Guidelines
Four publications on cancer treatment during pregnancy were published last week in the journal Lancet, serving as new treatme Read More...
Male breast cancer is often overlooked. In this interview with CBS news, Patrick Cobb, MD, F.A.C.P., a practicing medical oncologist at Frontier Cancer Center in Billings, Montana, provides important educational information on the subject. In addition to daily patient clinical support, Dr. Cobb is a dedicated patient advocate. He is the immediate past president of the Community Oncology Alliance (COA) and currently serves as the Chairman of COA’s Policy Committee.